W. Va. judge sides with drug distributors in bellwether opioid trial
From 2001 to 2017, the fatal overdose rate in Cabell County increased from 16.6 to 213.9 per 100,000. Judge finds no evidence of causation.
Walgreens to sell pharmacy wholesale business for $6.5B
AmerisourceBergen plans to buy most of Walgreens’ Alliance Healthcare business for $6.5 billion. The deal will let Walgreens focus more on its retail pharmacy and healthcare businesses.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Report: Prosecutors use Controlled Substances Act to investigate opioid makers, distributors
The Wall Street Journal reported that at least six companies' disclosures that they had received subpoenas were related to the investigation, and subpoenas for additional companies are expected in the coming months.
Report: Teva and 3 distributors reach $260M settlement in opioids case with Ohio counties
The Israeli drugmaker, plus AmerisourceBergen, Cardinal Health and McKesson, reached the settlement with Ohio's Cuyahoga and Summit counties. Walgreens did not manage to reach an agreement.
Report: Okla. judge acknowledges miscalculating part of $572M charge for J&J in opioids case
In other news, the three largest pharmaceutical distributors in the country - AmerisourceBergen, McKesson and Cardinal Health - were reportedly in talks to settle opioid litigation for $18 billion.
AmerisourceBergen’s Lash Group teams up with Medisafe to address patient adherence
Through their alliance, Medisafe will deliver real-time interventions to help patients stay adherent and will alert Lash Group's clinicians when patients are considered "at-risk."
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
DOJ recovered $2.5 billion in 2018 healthcare false claim cases
According to the DOJ, this is the ninth consecutive year that the organizations' civil healthcare fraud settlements and judgments have exceeded $2 billion.
How Besse Medical is innovating in inventory management
The company, which is a distributor of pharmaceuticals and a division of AmerisourceBergen, offers two inventory management systems: CubixxMD and PODIS Plus.
CAR-T has a lot of promise, but some big challenges remain, experts at BIO, ASCO say
Many issues around CAR-T remain to be hashed out, but many experts pointed to infrastructure and clinics' capabilities as crucial.
Report: Walgreens in talks to acquire one of largest drug distributors — AmerisourceBergen
In a move that could position Walgreens to own one of the largest drug distributors to retail pharmacies and physicians, the retail drugstore giant is in talks with Amerisource Bergen, according to The Wall Street Journal.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Morning Read: AmerisourceBergen buying PharMEDium for $2.58B, Peyton Manning to keynote at HIMSS 2016
Also, Sarepta Therapeutics Inc. raised $126.8 million, Quartet Health announced the appointment of Patrick Kennedy to its Board of Directors and Sickweather has developed the world’s first real-time map of illness.
McKesson beats Cardinal, AmerisourceBergen for big VA drug distribution contract
McKesson (NYSE:MCK) has won a U.S. Department of Veterans Affairs drug distribution contract that could be worth nearly $32 billion over eight years, beating out its top rivals Cardinal Health (NYSE:CAH) and AmerisourceBergen (NYSE:ABC). Winning such a potentially huge contract made McKesson popular on Wall Street and sent shares of the San Francisco-based company up […]
Generic drugs to fuel growth for Cardinal Health, other pharma wholesalers
As generic drugs increasingly replace brand names in the coming years, pharmaceuticals wholesalers like Cardinal Health (NYSE:CAH) will see their operating profits rise "dramatically," according to a report from Barclays Capital.
Cardinal Health’s dependence on top customers leaves it ‘vulnerable’
Cardinal Health (NYSE:CAH) renewal of a key drug distribution contract with Walgreen Co. earlier this month brings renewed focus on just how heavily reliant Cardinal is on its top two customers. In Cardinal's fiscal 2010, Walgreen (24 percent) and CVS (22 percent) combined for a 46 percent share of revenues. That's up from a combined 43 percent in 2008. Adam Fein, a pharmaceutical industry consultant with Pembroke Consulting, stated on his blog Drug Channels: "The data show a company that's increasingly at the mercy of its two dominant customers."
Has Cardinal Health started era of the global drug distributor?
With Cardinal Health Inc. (NYSE:CAH) buying a Chinese pharmaceuticals distributor, the Ohio company has become the first of the three major U.S. drug distributors to make a big investment outside North America. But it likely won't be the last time one of the Big Three look across the world's oceans in search of growth opportunities.